As noted by other groups [64, 65], we have identified Mitoxantrone, a drug that was used to treat acute myeloid leukaemia and multiple sclerosis, as a potential hit against Nsp3 in our virtual screening experiments. This evidence concerns the gene SH2D3C and acute myeloid leukemia.